Edible powder formula for osteonecrosis, tendon injury and meniscus injury

Abstract

The invention discloses an edible powder formula for osteonecrosis, tendon injury and meniscus injury. The edible powder formula comprises salvia miltiorrhiza, pseudo-ginseng, radix puerariae, radix pseudostellariae and angelica sinensis. Wherein the ratio of the components is as follows: 30-40% of salvia miltiorrhiza, 20-30% of pseudo-ginseng, 20-30% of kudzuvine root, 2-7% of radix pseudostellariae and Compared with the prior art, the formula of the edible powder for osteonecrosis, tendon injury and meniscus injury provided by the invention has the advantages that the symptoms of osteonecrosis, tendon injury and meniscus injury can be effectively improved, the preparation process is simple, and the edible powder for osteonecrosis, tendon injury and meniscus injury is convenient to take.

Description

Technical Field

[0001] The invention relates to the technical field of traditional Chinese medicines, in particular to an edible powder formula for bone necrosis, tendon injury and meniscus injury. Background Art

[0002] In today's society, with the accelerated pace of life and the diversification of exercise methods, the incidence of musculoskeletal system diseases is on the rise. Among them, osteonecrosis, tendon injuries, and meniscus injuries are relatively common and seriously affect patients' quality of life.

[0003] Osteonecrosis, especially femoral head necrosis, is a common difficult orthopedic disease. The causes of its onset are complex and diverse, and may be related to long-term and excessive use of hormones, alcoholism, trauma and other factors. Osteonecrosis can cause bone tissue to lose its normal blood supply, which in turn causes bone cell death and bone structure destruction, and may eventually lead to joint dysfunction or even disability. Patients often experience symptoms such as hip pain and limited movement, which bring great inconvenience to daily life and work. At present, the treatments for osteonecrosis mainly include drug therapy, physical therapy, surgical treatment, etc., but these methods often have problems such as limited efficacy, large side effects, and long treatment cycles. Summary of the Invention

[0004] The technical problem to be solved by the present invention is to overcome the above technical defects and provide a formula of edible powder for bone necrosis, tendon injury and meniscus injury which can effectively improve the symptoms of bone necrosis, tendon injury and meniscus injury, and has a simple preparation process and is easy to take.

[0005] In order to solve the above technical problems, the present invention provides a technical solution: an edible powder formula for treating bone necrosis, tendon injury and meniscus injury, comprising salvia miltiorrhiza, panax notoginseng, kudzu root, pseudoginseng and angelica sinensis;

[0006] The proportions of each component are salvia miltiorrhiza 30-40%, panax notoginseng 20-30%, kudzu root 20-30%, pseudoginseng 2-7%, and angelica 7-13%.

[0007] Preferably, the ratio of the components is 35% of Salvia miltiorrhiza, 25% of Panax notoginseng, 25% of Pueraria lobata, 5% of Pseudostellaria baicalensis, and 10% of Angelica sinensis.

[0008] Preferably, the method comprises the following steps:

[0009] S1: Take Chinese medicinal materials in equal proportions;

[0010] S2: Wash and dry the Chinese medicinal materials in S1;

[0011] S3: Grinding the dried raw materials to obtain Chinese medicine powder, and mixing the Chinese medicine powder;

[0012] S4: sifting to obtain edible powder;

[0013] S5: Packing and storage.

[0014] Preferably, the S1 contains 35% of Salvia miltiorrhiza, 25% of Panax notoginseng, 25% of Pueraria root, 5% of Pseudostellaria baicalensis, and 10% of Angelica sinensis.

[0015] Preferably, the drying temperature in S2 is 50-60° C., the drying time is 4-6 hours, and the water content is ≤8%.

[0016] Preferably, in S4, the Chinese medicine powder is sieved through a 120-mesh sieve.

[0017] Preferably, the edible powder is prepared as any one of capsules, tablets or granules.

[0018] The advantages of the present invention compared with the prior art are:

[0019] The present invention is based on the theory of traditional Chinese medicine, and carefully selects salvia miltiorrhiza, panax notoginseng, kudzu root, pseudoginseng, and angelica;

[0020] Among them, Danshen promotes blood circulation and removes blood stasis, which can improve local blood circulation, provide sufficient nutrition and oxygen to damaged tissues, and promote tissue repair;

[0021] Panax notoginseng can dissipate blood stasis, stop bleeding, reduce swelling and relieve pain, effectively relieving pain and swelling symptoms; Angelica sinensis can replenish blood and activate blood circulation, helping to regulate the body's qi and blood balance and enhance the body's self-repair ability;

[0022] Pueraria root has the effects of relieving muscles and reducing fever, raising yang and stopping diarrhea. Its various components work synergistically with each other to treat bone necrosis, tendon injuries, and meniscus injuries from multiple aspects, and can effectively improve related symptoms. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 This is a flow chart of the formulation of edible powder for treating bone necrosis, tendon injury and meniscus injury. DETAILED DESCRIPTION

[0024] The present invention will be described in further detail below with reference to the accompanying drawings.

[0025] Combined with attachment Figure 1 As shown, the edible powder formula for bone necrosis, tendon injury and meniscus injury includes salvia miltiorrhiza, Panax notoginseng, Pueraria root, Pseudostellaria baicalensis and Angelica sinensis;

[0026] The proportions of each component are salvia miltiorrhiza 30-40%, panax notoginseng 20-30%, kudzu root 20-30%, pseudoginseng 2-7%, and angelica 7-13%.

[0027] In one embodiment:

[0028] The proportions of each component are 35% of Salvia miltiorrhiza, 25% of Panax notoginseng, 25% of Pueraria root, 5% of Pseudostellariae pseudoginseng, and 10% of Angelica sinensis.

[0029] The specific use includes the following steps:

[0030] S1: Take Chinese medicinal materials in equal proportions;

[0031] S2: Wash and dry the Chinese medicinal materials in S1;

[0032] S3: Grinding the dried raw materials to obtain Chinese medicine powder, and mixing the Chinese medicine powder;

[0033] S4: sifting to obtain edible powder;

[0034] S5: Packing and storage.

[0035] The S1 contains 35% of Salvia miltiorrhiza, 25% of Panax notoginseng, 25% of Pueraria root, 5% of Pseudostellaria baicalensis, and 10% of Angelica sinensis. The S2 is dried at a temperature of 50-60° C. for 4-6 hours, and has a water content of ≤8%.

[0036] In S4, the Chinese medicine powder is passed through a 120-mesh sieve, and the edible powder is prepared into any one of capsules, tablets or granules.

[0037] In a specific implementation of the present invention, 35% of salvia miltiorrhiza, 25% of panax notoginseng, 25% of kudzu root, 5% of pseudoginseng, and 10% of angelica are taken in S1; the drying temperature in S2 is 50-60°C, the drying time is 4-6 hours, and the water content is ≤8%; in S4, the traditional Chinese medicine powder is sieved through a 120-mesh sieve, and the edible powder is prepared into any one of capsules, tablets, or granules.

[0038] When using, take it twice a day, once in the morning and once in the evening, after meals. Each serving contains 10 grams, and the course of treatment is 15 days.

[0039] The contents not described in detail in this specification belong to the prior art known to those skilled in the art.

[0040] Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making any creative work shall fall within the scope of protection of the present invention.

[0041] It should be noted that similar reference numerals and letters denote similar items in the following drawings, and therefore, once an item is defined in one drawing, it does not need to be further defined or explained in subsequent drawings.

[0042] In the description of the present invention, it should be understood that the terms "center", "longitudinal", "lateral", "length", "width", "thickness", "up", "down", "front", "back", "left", "right", "vertical", "horizontal", "top", "bottom", "inside", "outside", "clockwise", "counterclockwise" and the like to indicate orientations or positional relationships based on the orientations or positional relationships shown in the accompanying drawings, and are only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore should not be understood as limiting the present invention.

[0043] Furthermore, the terms "first" and "second" are used for descriptive purposes only and should not be construed as indicating or implying relative importance or implicitly specifying the number of the technical features being referred to. Thus, a feature identified as "first" or "second" may explicitly or implicitly include one or more of the features. In the description of the present invention, "plurality" means two or more, unless otherwise specifically defined.

[0044] In the present invention, unless otherwise expressly specified or limited, the terms "mounted," "connected," "connect," "fixed," etc. should be understood broadly. For example, they may refer to fixed connection, detachable connection, or integration; they may refer to direct connection or indirect connection through an intermediate medium; they may refer to internal communication between two components or interaction between two components. Those skilled in the art will understand the specific meanings of the above terms in the present invention based on specific circumstances.

[0045] In the present invention, unless otherwise expressly specified or limited, a first feature being "above" or "below" a second feature may include the first and second features being in direct contact, or may include the first and second features being in contact not directly but through another feature between them. Moreover, a first feature being "above," "above," and "above" a second feature includes the first feature being directly above and obliquely above the second feature, or simply indicates that the first feature is higher in level than the second feature. A first feature being "below," "below," and "below" a second feature includes the first feature being directly below and obliquely below the second feature, or simply indicates that the first feature is lower in level than the second feature.

[0046] The present invention and its embodiments are described above. This description is not restrictive. The drawings show only one embodiment of the present invention, and the actual structure is not limited thereto. In short, if a person skilled in the art is inspired by this and, without departing from the purpose of the present invention, designs structures and embodiments similar to this technical solution without inventiveness, they shall fall within the scope of protection of the present invention.

Claims

1. A formula of edible powder for treating bone necrosis, tendon injury and meniscus injury, characterized by: Including Danshen, Panax notoginseng, Pueraria root, Pseudostellaria baicalensis, and Angelica sinensis; The proportions of each component are salvia miltiorrhiza 30-40%, panax notoginseng 20-30%, kudzu root 20-30%, pseudoginseng 2-7%, and angelica 7-13%.

2. The edible powder formula for treating osteonecrosis, tendon injury and meniscus injury according to claim 1, characterized in that: The proportions of the components are 35% of Salvia miltiorrhiza, 25% of Panax notoginseng, 25% of Pueraria root, 5% of Pseudostellariae pseudoginseng and 10% of Angelica sinensis.

3. The edible powder formula for treating osteonecrosis, tendon injury and meniscus injury according to claim 1, characterized in that: The steps include: S1: Take Chinese medicinal materials in equal proportions; S2: Wash and dry the Chinese medicinal materials in S1; S3: Grinding the dried raw materials to obtain Chinese medicine powder, and mixing the Chinese medicine powder; S4: sifting to obtain edible powder; S5: Packing and storage.

4. The edible powder formula for treating osteonecrosis, tendon injury and meniscus injury according to claim 1, characterized in that: The S1 contains 35% of Salvia miltiorrhiza, 25% of Panax notoginseng, 25% of Pueraria root, 5% of Pseudostellaria baicalensis, and 10% of Angelica sinensis.

5. The edible powder formula for treating osteonecrosis, tendon injury and meniscus injury according to claim 1, characterized in that: The drying temperature in S2 is 50-60° C., the drying time is 4-6 hours, and the water content is ≤8%.

6. The edible powder formula for treating osteonecrosis, tendon injury and meniscus injury according to claim 1, characterized in that: In the step S4, the Chinese medicine powder is sieved through a 120-mesh sieve.

7. The edible powder formula for treating osteonecrosis, tendon injury and meniscus injury according to claim 1, characterized in that: The edible powder is prepared into any one of capsules, tablets or granules.

Images